Mehran Habibi, MD
Surgical Oncology · Miami, FLNPI 1770540536
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $55,853 of the $73,225 with a category attached, or 76.3%. 18 manufacturers reported payments, led by Dilon Technologies, Inc. at 56.1% of the total. Reporting peaked in 2021 at $39,958 and has fallen 88.7% since, to $4,532 in 2025. Among surgical oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $926.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dilon Technologies, Inc.$41K
- Hologic Inc$12K
- Focal Therapeutics, Inc.$7K
- Endomagnetics Ltd$7K
- Axogen$2K
- Bioptics, Inc.$2K
- plus $3K from 12 others
Across 16 payments — averaging $14,988 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dilon Technologies, Inc.$163K
- Medtronic$49K
- Cardinal Health 414 LLC$28K
What the payments were for
- Consulting fees$55,85376%
- Travel & lodging$8,95512%
- Food & beverage$8,02711%
- Entertainment$3901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dilon Technologies, Inc. | 23 | $41,065 |
| Hologic Inc | 11 | $11,830 |
| Focal Therapeutics, Inc. | 3 | $7,448 |
| Endomagnetics Ltd | 11 | $6,779 |
| Axogen | 9 | $1,886 |
| Bioptics, Inc. | 1 | $1,500 |
| Biom'up SA | 5 | $1,048 |
| Hologic Sales And Service, LLC | 5 | $463 |
| Elucent Medical | 2 | $419 |
| Molli Surgical (US) Inc | 1 | $236 |
| Merit Medical Systems Inc | 1 | $124 |
| Merck | 1 | $116 |
| KUB Technologies Inc. | 1 | $111 |
| Isono Health, Inc. | 1 | $95 |
| Carl Zeiss Meditec, Inc. | 1 | $55 |
| Solventum Corporation | 1 | $29 |
| Sirius Medical Systems | 1 | $12 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MARGINPROBE PROBE$39,000
- Localizer$3,285
- HemoBlast Bellows$1,715
- AVANCE NERVE GRAFT$1,513
- AxoGuard Nerve Connector$1,513
- AxoGuard Nerve Protector$1,513
- Magseed$1,272
- Magtrace$1,089
- HEMOBLAST$947
- BioZorb$618
- SENTIMAG$147
- Savi SCOUT$124
- NAVIGATOR BIONAVIGATION SYSTEM$120
- KEYTRUDA$116
- AIXPLORER ULTIMATE$114
- Mozart$111
How this compares
$73,225 in reported general payments places this provider in the 95th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Miami
- Neha GoelMiami$200K
- Horacio AsbunMiami$161K
- Kristin RojasMiami$57K
- Amit KhithaniMiami$32K
- Geoffrey YoungMiami$22K
- Nipun MerchantMiami$11K
- Meghan CrawleyMiami$5K
- Julie GrossmanMiami$4K
- Levan TsamalaidzeMiami$4K
- Ahkeel AllenMiami$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.